BackOrchestra BioMed Holdings Overview

Orchestra BioMed Holdings Total Liabilities

Track Orchestra BioMed Holdings's total liabilities ($86M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$86.28M
↑ 102.87% YoYΔ $43.75M vs prior year quarter

Peer trimmed avg / median

Loading

Orchestra BioMed Holdings Total Liabilities History

Loading

Orchestra BioMed Holdings vs. peers: Total Liabilities Comparison

Loading

Orchestra BioMed Holdings Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orchestra BioMed Holdings (OBIO) FAQ

As of the most recent data (June 2026), OBIO shows a total liabilities of $86M. That compares with $43M in the prior-year period — up 102.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OBIO's total liabilities is now $86M (was $43M) — a 102.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Orchestra BioMed Holdings is outperforming or lagging.

Tracking OBIO's total liabilities over time shows whether Orchestra BioMed Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $86M That compares with $43M in the prior-year period — up 102.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Orchestra BioMed Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $86M) with ownership activity and broader fundamentals.